hotspot -WSS

hotspot

author：Wikipedia 2025-09-30 11:58:02 - browse：7

Stain of a biopsy specimen of a rhabdoid tumor -- health coverage from STAT — Stain of a biopsy specimen of a rhabdoid tumor. Wikimedia Commons

Most targeted cancer drugs work like tranquilizer darts, snaring an overzealous gene that has spurred the cell into murderously rapid growth.

But many tumors don’t have a hyperactive gene. Like the mayhem in “Cat in the Hat,” they are enabled by parental absence. They grow because the genes that are meant to provide discipline, guiding the activity of other genes or self-destructing a cell whose DNA is too damaged, are broken or missing.

These tumors have bedeviled researchers for decades. Restoring or fixing a protein is far harder than breaking it. And that’s bad news for humanity: Cancer is far more likely to be caused by such “tumor-suppressor” genes than by one gene run amok.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： New Eli Lilly Alzheimer’s data poses Medicare coverage conundrum
Next article： What to expect at HLTH 2023, the health care industry conference

focus

WSS

The future of health care in the House

At ASCO, pharma leaders speak of advances in 'smart bomb' drugs

ASCO Daily Recap: Safety data from Novartis, survival from Pfizer

Was Amgen transparent enough on FDA's concern on cancer drug?

Analysis of telehealth claims data suggest service duplication

3 questions for the future of Biden's cancer moonshot

leisure time

hotspot

leisure time

At least 13 dead in Texas as scorching temps continue

BMI, flaws aside, is found to be useful estimate of body fat in youth

Hepatitis C has a cure — but many Americans still lack access to it

Cord blood banking comes at a high cost to babies

Sports medicine is finally prioritizing gender equality

Why age limits for politicians are a terrible idea

After affirmative action ruling, medical educators look to 'holistic review'

Bill would stop addiction treatment from triggering child abuse inquiry

Anesthesiologist group: stop taking Ozempic before surgery

ASCO: AstraZeneca's hat trick, and palliative care's spotlight

focus

ASCO: AstraZeneca's Tagrisso greatly slowed some lung cancers

Colorectal cancer study finds potential in overlooked immune cell

How to increase colonoscopy rates? Looks like an AI can help

Chemotherapy drug shortage eases slightly but still widespread

Chan Zuckerberg Biohub Chicago to focus on inflammation

In $4.8 billion deal, Bristol Myers Squibb to buy cancer player Mirati

explore

focus

hotspot

leisure time